Investing.comQwen · 实盘不做把握 7/10不做原因:已被定价
北京时间·🕒 发布 04:39:39·⟳ 抓取 04:40:19 +40s·⚡ 决策 09-04 05:25:15 +44m56s·53.5 天前
UiPath Q3营收超预期3%但指引仅持平，盘后暴跌近7%
营收beat 3%但指引持平，股价3个月涨62%后预期极高，盘后已暴跌6.9%（高点$20.88→低点$16.48）完成'卖事实'定价。做多无催化（指引未上调），做空已错过主跌（盘后-6.9%已完成），双向均无正期望。
📄 原文Investing.com↗ 原文
UiPath earnings matched, revenue topped estimates
Wall Street indexes close more than 1% higher as Treasury yields slide Investing.com - UiPath (NYSE: PATH) reported thi…
不做 UiPath（PATH.US）
营收超预期3%但指引仅持平，股价3月涨62%后预期极高，盘后已暴跌6.9%完成'卖事实'定价。做多无新催化（指引未上调），做空已错过主跌且面临超跌反弹风险，双向均无正期望edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
UiPath Q3营收超预期3.1%但EPS持平、Q4和全年指引仅与预期一致，在股价3个月涨62%的高预期下构成'利好出尽'。盘后股价从$20.88急坠至$16.48（-6.9%），市场已完成重定价。无指引上调意味着增长斜率未加速，无法支撑进一步做多；而盘后主跌已完成，次日做空面临超跌反弹风险。无可交易edge。
🔎 新鲜度:最早出现 2026-09-03 · 扩散 high · price-in 风险 high ↗
反向证据
- 做多前查反向 · 来源 stock_quote · 日期 2026-09-03 · 影响 invalidates
盘后从$20.88跌至$16.48后小幅回升至$16.96，但指引未上调、增长斜率未加速，无基本面支撑反弹
检索:UiPath盘后暴跌后是否有超跌反弹逻辑 - 做空前查反向 · 来源 stock_quote · 日期 2026-09-03 · 影响 invalidates
主跌已在盘后完成（-6.9%），次日面临超跌反弹和空头回补风险；营收实际超预期不构成基本面恶化
检索:盘后-6.9%后次日做空是否有edge
先例如何影响了这次决策
对本次决策的影响:盘后实时反应替代了先例校准的必要性；-6.9%跌幅确认无剩余做多edge
方向:盘后-6.9%的实时市场反应已比历史先例更直接地定价了本次事件
涨幅量级:无需先例校准——盘后已完成主要定价
形态:盘后冲高$20.88→急坠$16.48是典型'见光死/卖事实'模式
工具执行结果 · 成功 3 · 降级 1 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 316 ms
{"result": "search_processed_events:agent query=`path earnings $410 million revenue | uipath 2027 fiscal year guidance | uipath path q3 earnings revenue beat`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 70.1/72 小时、7397 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选，不能据此证明消息首发或不是重复；按当前事件继续正常研判。"} - stock_quote 降级 stock_tools HTTP · 4,588 ms
{ - search_case_library 成功 stock_tools HTTP · 124 ms
{"result": "search_case_library「PATH.US」—— 与这些标的相关的自家决策案例(本页 4 条,该标的全历史相关记录共 4 条；ENTER 只按该标的自己的腿统计):\n◆ PATH.US：相关历史决策 4 条 · 其中该标的 ENTER 0 条(0.0%) · 我们从没在这只票上 ENTER 过\n【对所查标的真 ENTER 过的:0 条 —— 相关案例里没有该标的自己的 ENTER 腿】\n【最近 4 条其它决策(多为「不做」,用来看这票最近在被什么消息刷屏)】\n• 2026-09-03 UTC 不做 · 事件:Seeking Alpha发布周四盘后美股 - stock_quote 成功 stock_tools HTTP · 255 ms
{
原文全文
展开原文 · 981 字
Wall Street indexes close more than 1% higher as Treasury yields slide
Investing.com - UiPath (NYSE: PATH) reported third quarter EPS of $0.15, in line with the analyst estimate of $0.15. Revenue for the quarter came in at $410.26M versus the consensus estimate of $397.77M.
Guidance
UiPath sees Q3 2027 revenue of $440.00M-$445.00M versus the analyst consensus of $441.20M.
UiPath sees FY 2027 revenue of $1.79B-$1.79B versus the analyst consensus of $1.78B.
UiPath’s stock price closed at $18.24. It is up 62.28% in the last 3 months and up 68.11% in the last 12 months.
UiPath saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See UiPath’s stock price’s past reactions to earnings here.
According to InvestingPro, UiPath’s Financial Health score is "great performance".
Check out UiPath’s recent earnings performance, and UiPath’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Investing.com - UiPath (NYSE: PATH) reported third quarter EPS of $0.15, in line with the analyst estimate of $0.15. Revenue for the quarter came in at $410.26M versus the consensus estimate of $397.77M.
Guidance
UiPath sees Q3 2027 revenue of $440.00M-$445.00M versus the analyst consensus of $441.20M.
UiPath sees FY 2027 revenue of $1.79B-$1.79B versus the analyst consensus of $1.78B.
UiPath’s stock price closed at $18.24. It is up 62.28% in the last 3 months and up 68.11% in the last 12 months.
UiPath saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See UiPath’s stock price’s past reactions to earnings here.
According to InvestingPro, UiPath’s Financial Health score is "great performance".
Check out UiPath’s recent earnings performance, and UiPath’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。